Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gabriela Gruia currently holds 12,555 shares of TScan Therapeutics, Inc. (TCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gabriela Gruia has been a net neutral trader of TCRX stock. They have purchased $0 and sold $0 worth of shares.
Gabriela Gruia's most recent insider trade was on Jun 16, 2026, when they sold 12,555 shares at $0.00 per share.
Gabriela Gruia serves as Executive at TScan Therapeutics, Inc. (TCRX). They have executed 4 insider transactions totaling $0 over their tenure at the company.
Gabriela Gruia holds the position of Executive at TScan Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Gabriela Gruia has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Gabriela Gruia was on Jun 16, 2026, when they purchased $0 worth of APRE shares. This transaction involved 12,555 shares at N/A per share.
Gabriela Gruia currently owns 12,555 shares of TScan Therapeutics, Inc. (TCRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gabriela Gruia's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gabriela Gruia has 4 Form 4 filings on record as an insider at TScan Therapeutics, Inc..
Set alerts for Gabriela Gruia and 40,000+ other insiders.